Kelly Financial Services’s Iterum Therapeutics ITRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-120
| Closed | -$137 | – | 427 |
|
|
2024
Q2 | $137 | Hold |
120
| – | – | ﹤0.01% | 748 |
|
|
2024
Q1 | $185 | Hold |
120
| – | – | ﹤0.01% | 741 |
|
|
2023
Q4 | $236 | Hold |
120
| – | – | ﹤0.01% | 733 |
|
|
2023
Q3 | $96 | Hold |
120
| – | – | ﹤0.01% | 732 |
|
|
2023
Q2 | $128 | Hold |
120
| – | – | ﹤0.01% | 695 |
|
|
2023
Q1 | $120 | Hold |
120
| – | – | ﹤0.01% | 672 |
|
|
2022
Q4 | $101 | Hold |
120
| – | – | ﹤0.01% | 660 |
|
|
2022
Q3 | $194 | Hold |
120
| – | – | ﹤0.01% | 654 |
|
|
2022
Q2 | $360 | Hold |
120
| – | – | ﹤0.01% | 620 |
|
|
2022
Q1 | $639 | Hold |
120
| – | – | ﹤0.01% | 592 |
|
|
2021
Q4 | $705 | Hold |
120
| – | – | ﹤0.01% | 606 |
|
|
2021
Q3 | $1.01K | Sell |
120
-157
| -57% | -$1.32K | ﹤0.01% | 572 |
|
|
2021
Q2 | $1.8M | Buy |
277
+157
| +131% | +$1.02M | 0.07% | 83 |
|
|
2021
Q1 | $2.54K | Buy |
+120
| New | +$2.54K | ﹤0.01% | 481 |
|